Top compounds associated with response to C11orf65


Feature Type Standardized
Nominal ANOVA
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA selumetinib:tretinoin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.004
mRNA chlorambucil CTRPv2 pan-cancer AAC -0.088 0.005
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.1 0.005
mRNA selumetinib:JQ-1 (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.094 0.005
mRNA CHIR-99021 CTRPv2 pan-cancer AAC -0.09 0.006
mRNA niclosamide CTRPv2 pan-cancer AAC 0.096 0.007
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.084 0.007
mRNA AZD6244 CTRPv2 pan-cancer AAC -0.095 0.007
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.089 0.007
Download CSV